CDSCO panel Approves Sanofi's Protocol Amendment Proposal for to study Fitusiran Dr. Divya Colin2 Jun 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved drug major...
Sanofi concludes acquisition of Inhibrx Ruchika Sharma2 Jun 2024 11:00 AM ISTParis: Sanofi has announced the completion of its acquisition of Inhibrx, Inc. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s...
USFDA requests additional data on Sanofi Dupixent for treating smoker's lung Ruchika Sharma31 May 2024 3:16 PM ISTParis: Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) requested additional efficacy analyses on the efficacy...
Sanofi Sarclisa accepted for USFDA priority review for transplant-ineligible newly diagnosed multiple myeloma Ruchika Sharma27 May 2024 11:30 AM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Sanofi, Formation Bio, OpenAI collaborate to build AI-powered software to accelerate drug development Ruchika Sharma21 May 2024 9:30 AM ISTParis: Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to...
Submit preliminary analysis of primary data of subjects above 18 years in India: CDSCO Panel Tells Sanofi on Amlitelimab study Dr. Divya Colin19 May 2024 6:00 PM ISTNew Delhi: After considering the phase III clinical study protocol of the monoclonal antibody Amlitelimab in the treatment of moderate-to-severe...
Sanofi, Novavax ink pact to co-commercialize COVID vaccine, develop novel flu-COVID combination vaccines Ruchika Sharma12 May 2024 10:00 AM ISTParis: Sanofi has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US to develop...
USFDA approves Gland Pharma Plerixafor Injection Ruchika Sharma7 May 2024 1:30 PM ISTHyderabad: Generic injectable-focused pharmaceutical company, Gland Pharma Limited, has received approval from the United States Food and Drug...
Nirsevimab use may reduce infant hospitalizations due to RSV by 82 percent: Lancet Dr. Kamal Kant Kohli3 May 2024 7:00 PM ISTNirsevimab use may reduce infant hospitalizations due to respiratory syncytial virus (RSV) by 82 percent, shows real world evidence published in The...
Submit post-marketing safety data of Belumosudil in Chronic graft versus host disease: CDSCO Panel Tells Sanofi Dr. Divya Colin21 April 2024 6:00 PM ISTNew Delhi: Responding to the proposal presented by the drug major Sanofi to import and market Belumosudil tablets 200 mg, the Subject Expert Committee...
Innate Pharma announces advancement of Sanofi-developed NK Cell Engager SAR443579/ IPH6101 progressing to Phase 2 for blood cancer patients Ruchika Sharma15 April 2024 3:17 PM ISTFrance: Innate Pharma SA has announced that the first patient was dosed in the Phase 2 dose expansion part of the Sanofi-sponsored clinical trial...
Sanofi new polio vaccine gets nod in India Ruchika Sharma6 April 2024 3:00 PM ISTNew Delhi: Drug giant Sanofi has received a nod for an alternative injectable vaccine, IMOVAX-Polio, to replace the widely used Inactivated Polio...
